HK Stock MarketDetailed Quotes

01801 INNOVENT BIO

Watchlist
  • 39.050
  • +0.900+2.36%
Noon Break Apr 25 12:00 CST
63.37BMarket Cap-55865P/E (TTM)

INNOVENT BIO Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
36.21%6.21B
20.63%2.7B
6.71%4.56B
15.34%2.24B
11.08%4.27B
97.29%1.94B
266.94%3.84B
184.85%984.21M
10,953.34%1.05B
7,688.93%345.52M
Operating income
36.21%6.21B
20.63%2.7B
6.71%4.56B
15.34%2.24B
11.08%4.27B
97.29%1.94B
266.94%3.84B
184.85%984.21M
10,953.34%1.05B
7,688.93%345.52M
Cost of sales
-22.05%-1.14B
-7.02%-504.62M
-84.23%-930.99M
-117.42%-471.53M
-30.32%-505.34M
-17.35%-216.88M
-210.51%-387.76M
-351.30%-184.82M
---124.88M
---40.95M
Operating expenses
-22.05%-1.14B
-7.02%-504.62M
-84.23%-930.99M
-117.42%-471.53M
-30.32%-505.34M
-17.35%-216.88M
-210.51%-387.76M
-351.30%-184.82M
-124.88M
-40.95M
Gross profit
39.84%5.07B
24.26%2.2B
-3.69%3.63B
2.50%1.77B
8.92%3.76B
115.77%1.72B
274.58%3.46B
162.47%799.39M
9,635.64%922.65M
6,765.76%304.57M
Selling expenses
-19.68%-3.1B
3.61%-1.35B
1.12%-2.59B
-28.93%-1.4B
-95.41%-2.62B
-142.76%-1.08B
-93.62%-1.34B
-67.45%-446.62M
-409.18%-692.52M
-2,542.37%-266.72M
Administrative expenses
10.20%-750.28M
9.66%-368.39M
-3.66%-835.49M
-32.46%-407.8M
-84.50%-806.01M
-64.78%-307.87M
-71.12%-436.87M
-139.19%-186.84M
-15.88%-255.3M
-6.84%-78.11M
Research and development expenses
22.42%-2.23B
21.43%-922.82M
-23.63%-2.87B
-20.54%-1.17B
-25.44%-2.32B
-20.59%-974.32M
-43.00%-1.85B
-20.46%-807.95M
-5.98%-1.29B
-59.68%-670.7M
Special items of operating profit
-106.14%-37.06M
-8.48%235.89M
201.40%603.31M
176.99%257.73M
3.61%-594.98M
-578.42%-334.75M
-81.24%-617.24M
110.16%69.97M
91.96%-340.57M
-92.98%33.29M
Operating profit
49.45%-1.05B
78.43%-205.82M
19.79%-2.07B
2.25%-954.35M
-226.34%-2.58B
-70.67%-976.3M
52.40%-790.36M
15.59%-572.05M
71.39%-1.66B
-2,644.94%-677.67M
Financing cost
3.02%-98.62M
-12.85%-50.29M
-62.81%-101.7M
-64.43%-44.57M
8.61%-62.46M
16.89%-27.1M
-14.89%-68.35M
11.22%-32.61M
13.74%-59.49M
-11.63%-36.73M
Earning before tax
47.27%-1.14B
74.36%-256.11M
17.84%-2.17B
0.45%-998.91M
-207.64%-2.64B
-65.94%-1B
50.07%-858.71M
15.36%-604.67M
70.71%-1.72B
-1,140.37%-714.41M
Tax
1,423.69%116.5M
141.43%116.96M
89.89%-8.8M
31,971.05%48.44M
37.70%-87.04M
95.69%-152K
---139.71M
---3.53M
----
----
After-tax profit from continuing operations
52.83%-1.03B
85.36%-139.15M
20.14%-2.18B
5.29%-950.47M
-173.31%-2.73B
-65.01%-1B
41.95%-998.42M
14.87%-608.19M
70.71%-1.72B
-1,140.37%-714.41M
Earning after tax
52.83%-1.03B
85.36%-139.15M
20.14%-2.18B
5.29%-950.47M
-173.31%-2.73B
-65.01%-1B
41.95%-998.42M
14.87%-608.19M
70.71%-1.72B
-1,140.37%-714.41M
Profit attributable to shareholders
52.83%-1.03B
85.36%-139.15M
20.14%-2.18B
5.29%-950.47M
-173.31%-2.73B
-65.01%-1B
41.95%-998.42M
14.87%-608.19M
70.20%-1.72B
-1,727.57%-714.41M
Basic earnings per share
54.79%-0.66
86.15%-0.09
22.34%-1.46
5.80%-0.65
-154.05%-1.88
-50.00%-0.69
49.32%-0.74
25.81%-0.46
91.53%-1.46
-306.67%-0.62
Diluted earnings per share
54.79%-0.66
86.15%-0.09
22.34%-1.46
5.80%-0.65
-154.05%-1.88
-50.00%-0.69
49.32%-0.74
25.81%-0.46
91.53%-1.46
47.01%-0.62
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover 36.21%6.21B20.63%2.7B6.71%4.56B15.34%2.24B11.08%4.27B97.29%1.94B266.94%3.84B184.85%984.21M10,953.34%1.05B7,688.93%345.52M
Operating income 36.21%6.21B20.63%2.7B6.71%4.56B15.34%2.24B11.08%4.27B97.29%1.94B266.94%3.84B184.85%984.21M10,953.34%1.05B7,688.93%345.52M
Cost of sales -22.05%-1.14B-7.02%-504.62M-84.23%-930.99M-117.42%-471.53M-30.32%-505.34M-17.35%-216.88M-210.51%-387.76M-351.30%-184.82M---124.88M---40.95M
Operating expenses -22.05%-1.14B-7.02%-504.62M-84.23%-930.99M-117.42%-471.53M-30.32%-505.34M-17.35%-216.88M-210.51%-387.76M-351.30%-184.82M-124.88M-40.95M
Gross profit 39.84%5.07B24.26%2.2B-3.69%3.63B2.50%1.77B8.92%3.76B115.77%1.72B274.58%3.46B162.47%799.39M9,635.64%922.65M6,765.76%304.57M
Selling expenses -19.68%-3.1B3.61%-1.35B1.12%-2.59B-28.93%-1.4B-95.41%-2.62B-142.76%-1.08B-93.62%-1.34B-67.45%-446.62M-409.18%-692.52M-2,542.37%-266.72M
Administrative expenses 10.20%-750.28M9.66%-368.39M-3.66%-835.49M-32.46%-407.8M-84.50%-806.01M-64.78%-307.87M-71.12%-436.87M-139.19%-186.84M-15.88%-255.3M-6.84%-78.11M
Research and development expenses 22.42%-2.23B21.43%-922.82M-23.63%-2.87B-20.54%-1.17B-25.44%-2.32B-20.59%-974.32M-43.00%-1.85B-20.46%-807.95M-5.98%-1.29B-59.68%-670.7M
Special items of operating profit -106.14%-37.06M-8.48%235.89M201.40%603.31M176.99%257.73M3.61%-594.98M-578.42%-334.75M-81.24%-617.24M110.16%69.97M91.96%-340.57M-92.98%33.29M
Operating profit 49.45%-1.05B78.43%-205.82M19.79%-2.07B2.25%-954.35M-226.34%-2.58B-70.67%-976.3M52.40%-790.36M15.59%-572.05M71.39%-1.66B-2,644.94%-677.67M
Financing cost 3.02%-98.62M-12.85%-50.29M-62.81%-101.7M-64.43%-44.57M8.61%-62.46M16.89%-27.1M-14.89%-68.35M11.22%-32.61M13.74%-59.49M-11.63%-36.73M
Earning before tax 47.27%-1.14B74.36%-256.11M17.84%-2.17B0.45%-998.91M-207.64%-2.64B-65.94%-1B50.07%-858.71M15.36%-604.67M70.71%-1.72B-1,140.37%-714.41M
Tax 1,423.69%116.5M141.43%116.96M89.89%-8.8M31,971.05%48.44M37.70%-87.04M95.69%-152K---139.71M---3.53M--------
After-tax profit from continuing operations 52.83%-1.03B85.36%-139.15M20.14%-2.18B5.29%-950.47M-173.31%-2.73B-65.01%-1B41.95%-998.42M14.87%-608.19M70.71%-1.72B-1,140.37%-714.41M
Earning after tax 52.83%-1.03B85.36%-139.15M20.14%-2.18B5.29%-950.47M-173.31%-2.73B-65.01%-1B41.95%-998.42M14.87%-608.19M70.71%-1.72B-1,140.37%-714.41M
Profit attributable to shareholders 52.83%-1.03B85.36%-139.15M20.14%-2.18B5.29%-950.47M-173.31%-2.73B-65.01%-1B41.95%-998.42M14.87%-608.19M70.20%-1.72B-1,727.57%-714.41M
Basic earnings per share 54.79%-0.6686.15%-0.0922.34%-1.465.80%-0.65-154.05%-1.88-50.00%-0.6949.32%-0.7425.81%-0.4691.53%-1.46-306.67%-0.62
Diluted earnings per share 54.79%-0.6686.15%-0.0922.34%-1.465.80%-0.65-154.05%-1.88-50.00%-0.6949.32%-0.7425.81%-0.4691.53%-1.4647.01%-0.62
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg